Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2024-03-12 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), which pertains to share certificate loss and related disclosures. The content is a notification about a specific event (loss of share certificates) and does not contain financial data, management discussion, or report content. It is not an annual report, earnings release, or any financial report. It is also not a director's dealing or share issue announcement. This type of document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2024-03-12 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (Bombay Stock Exchange and National Stock Exchange of India) regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to reporting share certificate loss. The content is a notification about a specific shareholder's lost share certificates, including certificate numbers and share counts. There is no financial data, no report or presentation, no voting results, no management or board changes, no earnings or audit information. This type of document is a regulatory announcement related to shareholding records and compliance, fitting best under Regulatory Filings (RNS) as it does not fit other more specific categories.
2024-03-12 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter dated 11th March 2024 from Sanofi India Limited addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of a Notice to Shareholders about the transfer of shares to the Investor Education and Protection Fund (IEPF). The letter encloses copies of the notice published in newspapers on 8th March 2024. The content is primarily an announcement of the publication of a notice to shareholders, not the notice itself or any detailed report. The document length is about 11,949 characters, but the content is focused on informing the exchanges about the publication of a notice, which fits the definition of a Report Publication Announcement (RPA). There is no detailed financial data, management discussion, or regulatory filing content beyond the announcement. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2024-03-11 English
Please find enclosed copies of the Notice to Shareholders of the Company regarding transfer of shares to IEPF, published on 8th March, 2024.
Report Publication Announcement Classification · 95% confidence The document is a letter dated 11th March 2024 from Sanofi India Limited addressed to stock exchanges (BSE and NSE) regarding the newspaper publication of a Notice to Shareholders about transfer of shares to the Investor Education and Protection Fund (IEPF). The letter encloses copies of the notice published in newspapers on 8th March 2024. The content is primarily an announcement of the publication of a notice to shareholders, not the notice itself or any detailed report. The document length is about 11,949 characters, but the content is focused on informing the exchanges about the publication of a notice, which fits the definition of a Report Publication Announcement (RPA). There is no financial data, management discussion, or detailed report content. Therefore, the document is best classified as a Report Publication Announcement (RPA).
2024-03-11 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), which pertains to share certificate loss and related disclosures. The content is about notifying the exchange of lost share certificates and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory disclosure related to shareholding but does not fit into categories like Major Shareholding Notification (MRQ) since it is about lost certificates, not ownership changes. It is not a report or announcement of financial results or governance changes. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-11 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the exchange of lost share certificates and does not contain financial data, earnings, management discussion, or any report publication. It is a regulatory disclosure related to shareholding but not a major shareholding notification or director's dealing. Given the nature and length (1601 characters), it is a regulatory filing that does not fit into other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-03-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.